FDAnews Drug Daily Bulletin

Fabry Disease Group Moves to Pry Patent From Drugmaker

April 7, 2011
Sufferers from a rare condition called Fabry disease, led by local families and a McCandless attorney, launched a second effort Tuesday to pry loose the patent to produce the only drug approved for its treatment in the United States.
Pittsburgh Post-Gazette